DMKJ
COGT icon

David M. Knott Jr’s Cogent Biosciences COGT Stock Holding History

David M. Knott Jr’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.3M Buy
111,081
+7,081
+7% +$248K 2.27% 13
2026
Q1 		$4M Buy
104,000
+2,000
+2% +$73.9K 2.38% 13
2025
Q4 		$3.62M Buy
+102,000
New +$2.87M 1.68% 13
2025
Q2 		– Sell
-213,302
Closed -$1.28M – 88
2025
Q1 		$1.28M Buy
+213,302
New +$1.67M 0.6% 24

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

David M. Knott Jr's COGT Position: Q2 2026 in Review

David M. Knott Jr increased its Cogent Biosciences (COGT) stake by 6.8% in Q2 2026, buying an estimated $248K and bringing the position to 111,081 shares worth $4.3M. The position accounts for 2.27% of the portfolio, ranked #13.

David M. Knott Jr first reported a position in COGT in Q1 2025 and has held it in 4 quarters since. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • David M. Knott Jr held 111,081 shares of Cogent Biosciences worth $4.3M as of Q2 2026.
  • David M. Knott Jr bought 7,081 Cogent Biosciences shares in Q2 2026, an estimated $248K.
  • Cogent Biosciences made up 2.27% of David M. Knott Jr's portfolio in Q2 2026, its #13 holding.
  • David M. Knott Jr first reported a position in Cogent Biosciences in Q1 2025 and has held it in 4 quarters since.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on David M. Knott Jr's 13F filing for Q2 2026, filed 12 Aug 2026.